Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Tests brain-computer interface control of assistive devices in people with paralysis

Tests whether people with paralysis can use brain activity to control assistive devices.

Plain-language title generated from the registry record
Registry title: Control of Assistive Devices Via Brain-Computer Interface Technology

Key facts

Where
Phoenix, United StatesSee the site

Where in United States

  • Barrow Neurological InstitutePhoenix, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Neuralink Corp
Trial code
NCT06710626
Record updated
5 June 2025
Original description
The CONVOY Study is a clinical trial designed to explore the feasibility of participants from the PRIME Study (NCT06429735) using the N1 Implant to control various assistive devices. The main goal is to determine whether participants can successfully modulate their brain activity to control devices, such as an Assistive Robotic Arm (ARA). This study will assess the effectiveness, consistency, and safety of neural control using the ARA and other assistive devices.Read full original descriptionShow less

CONVOY: An Early Feasibility Study of Neural Control of Assistive Devices Via Brain-Computer Interface Technology

The CONVOY Study is a clinical trial designed to explore the feasibility of participants from the PRIME Study (NCT06429735) using the N1 Implant to control various assistive devices. The main goal is to determine whether participants can successfully modulate their brain activity to control devices, such as an Assistive Robotic Arm (ARA). This study will assess the effectiveness, consistency, and safety of neural control using the ARA and other assistive devices.

Inclusion: Continued enrollment in the PRIME Study; Implanted with the N1 Implant.

Exclusion: Explantation or deactivation of the N1 Implant; Insufficient N1 Implant BCI performance demonstrated; Any condition which, in the opinion of the Investigator, would compromise the candidate's ability to safely participate in the study; Lack of a suitable physical space to perform research sessions.

ClinicalTrials.gov NCT06710626